InventaBioTech 10-Q 14 Aug 15 2015 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - Jun. 30, 2015 - USD ($)	Total
Document and Entity Information [Abstract]
Document Type	10-Q
Entity Registrant Name	Westmountain Company
Entity Central Index Key	1,421,603
Document Period End Date	Jun. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,015
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding	9,517,402
Entity Public Float	$ 300,878
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current Assets:
Cash and cash equivalents	$ 303,474	$ 445,411
Investments in marketable securities	138,549	1,006,230
Accounts receivable, related parties	12,000	41,125
Accounts receivable	28,614	$ 12,300
Income tax receivable	14,457
Note receivable, related parties	65,448	$ 25,937
Prepaid expenses	13,021	$ 9,807
Deferred tax asset	209,390
Total current assets	784,953	$ 1,540,810
Property and equipment, net of accumulated depreciation of $9,987 and $9,473, respectively	6,856	6,173
Investments in nonmarketable securities, at cost	31,645	31,645
Total assets	823,454	1,578,628
Current Liabilities:
Accounts payable and accrued liabilities	$ 32,564	37,293
Deferred tax liability		107,958
Income tax payable		68,662
Total current liabilities	$ 32,564	213,913
Total liabilities	$ 32,564	$ 213,913
Shareholders' Equity:
Preferred stock, $0.10 par value; 1,000,000 shares authorized, none issued and outstanding
Common stock, $.001 par value; 50,000,000 shares authorized, 9,517,402 shares issued and outstanding	$ 9,518	$ 9,518
Additional paid-in capital	927,355	927,355
Accumulated earnings (deficit)	(140,599)	8,952
Other comprehensive income, net	(5,384)	418,890
Total shareholders' equity	790,890	1,364,715
Total liabilities and shareholders' equity	$ 823,454	$ 1,578,628

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Assets
Accumulated depreciation	$ 10,502	$ 9,473
Shareholders' Equity:
Preferred stock, par value per share	$ 0.10	$ 0.10
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	9,517,402	9,517,402
Common stock, shares outstanding	9,517,402	9,517,402

Consolidated Statements of Oper

Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Revenue:
Advisory/consulting fees, related parties	$ 53,600	$ 38,000
Advisory/consulting fees		12,600
Total revenue	$ 53,600	50,600
Operating expenses:
Selling, general and administrative expenses	84,381	100,264
Total operating expenses	84,381	100,264
Loss from operations	(30,781)	$ (49,664)
Other (expense) income
Interest income	$ 1,886
Dividend income on nonmarketable securities		$ 180,950
Loss on available for sale marketable securities	$ (193,634)
Total other (expense) income	(191,748)	$ 180,950
Net income (loss) before income taxes	(222,529)	131,286
Income tax benefit	(82,460)	(81)
Net (loss) income	(149,551)	90,518
Other comprehensive (loss) income
Unrealized (loss) income on investments in marketable equity securities, net of tax	(274,362)	3,321
Comprehensive (loss) income	$ (414,431)	$ 134,688
Basic net (loss) income per share	$ (0.01)	$ 0.01
Diluted net (loss) income per share	$ (0.01)	$ 0.01
Basic weighted average common shares outstanding	9,517,402	9,517,402
Diluted weighted average common shares outstanding	9,517,402	9,601,985

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net (loss) income	$ (149,551)	$ 90,518
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	$ 1,029	793
Realized loss on available for sale marketable securities		$ 5,955
Loss on impairment of available for sale marketable securities	$ 193,634
Deferred income benefit	(67,574)	$ (8,497)
Changes in operating assets and operating liabilities:
Prepaid expenses and other current assets	(7,725)	2,007
Accounts receivable	(16,314)	6,415
Accounts receivable, related parties	29,125	388,800
Accounts payable and accrued liabilities	(4,731)	(43,056)
Income tax receivable	$ (83,119)	(8,441)
Deferred revenue		(33,559)
Net cash (used in) provided by operating activities	$ (105,226)	$ 400,935
Cash flows from investing activities:
Loan to related party	(35,000)
Purchases of equipment	$ (1,711)
Proceeds from the sale of available for sale securities		$ 936
Purchases of investments		(52)
Net cash (used in) provided by investing activities	$ (36,711)	884
Net change in cash and cash equivalents	(141,937)	401,819
Cash and cash equivalents, beginning of period	445,411	57,992
Cash and cash equivalents, end of period	303,474	459,811
Supplemental disclosure of cash flow information:
Cash paid during the period for Income tax	$ 62,650	$ 42,000
Cash paid during the period for Interest
Non cash investing and financing activities:
Unrealized (income) loss on investments in marketable securities	$ 424,274	$ 181,841

Nature of Organization and Summ

Nature of Organization and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Organization and Summary of Significant Accounting Policies	(1) Nature of Organization and Summary of Significant Accounting Policies Nature of Organization and Basis of Presentation WestMountain Company, formerly known as WestMountain Asset Management, Inc. , ("we"," our" or the "Company"), was incorporated in the state of Colorado on October 18, 2007 and on this date approved its business plan and commenced operations. The consolidated financial statements include the financial information of WestMountain Company and its wholly owned subsidiaries, WestMountain Business Consulting, Inc., WestMountain Allocation Analytics, Inc. and WestMountain Valuation Services Inc. All significant intercompany accounts and transactions have been eliminated. Unaudited Financial Information The accompanying financial information as of March 31, 2015 and for the three months ended March 31, 2015 and 2014 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company's financial position at March 31, 2015 and its operating results for the three months ended March 31, 2015 and 2014 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company's annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") for the year ended December 31, 2014. The results of operations for the three months ended March 31, 2015 is not necessarily an indication of operating results to be expected for the year. Commitments and Contingencies Based on currently available information, the Company believes that it is remote that future costs related to known contingent liability exposures will exceed current accruals by an amount that would have a material adverse impact on our financial statements. As the Company learns new facts concerning contingencies, the Company reassesses its position both with respect to accrued liabilities and other potential exposures. In the case of all known contingencies, the Company accrues a liability when the loss is probable and the amount is reasonably estimable. The Company does not reduce these liabilities for potential insurance or third-party recoveries. Income Tax Receivable As of March 31, 2015, the Company had an income tax receivable of $4,417 that is related to estimated tax payments on deposit with federal and state taxing authorities. Fair Value of Financial Instruments Available-for-sale securities are accounted for on a specific identification basis. As of March 31, 2015 and December 31, 2014 respectively, we held available-for-sale marketable securities with an aggregate fair value of $376,716 and $1,006,230 respectively. As of March 31, 2015, all of our available-for-sale securities were invested in publically traded equity holdings. Available-for-sale securities were classified as current based on the percentage of the equity controlled by the Company as well as our intended use of the assets. The Company recognized unrealized losses, net of tax, in accumulated other comprehensive (loss) income for the three months ended March 31, 2015 and 2014 in the amounts of ($274,362) and $3,321, respectively. The Company's assets measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 at March 31, 2015 and December 31, 2014, were as follows: Assets and Liabilities Measured at Fair Value on a Recurring Basis as of March 31, 2015 Quoted Prices in Significant Active Markets for Other Significant Identical Assets and Observable Unobservable Balance as of Liabilities Inputs Inputs March 31, Description (Level 1) (Level 2) (Level 3) 2015 Assets: Available-for-sale marketable securities $376,716 $ - $ - $376,716 Assets and Liabilities Measured at Fair Value on a Recurring Basis as of December 31, 2014 Quoted Prices in Significant Active Markets for Other Significant Identical Assets and Observable Unobservable Balance as of Liabilities Inputs Inputs December 31, Description (Level 1) (Level 2) (Level 3) 2014 Assets: Available-for-sale marketable securities $1,006,230 $ - $ - $1,006,230

Investments

Investments	6 Months Ended
	Jun. 30, 2015
Investments, Debt and Equity Securities [Abstract]
Investments	(2) Investments Investments in Available for Sale Marketable Securities The Company's investments in available for sale marketable securities as of March 31, 2015 and December 31, 2014 are summarized below. As of March 31, 2015 Accumulated Share Market/Cost Unrealized Company Name Shares Cost Price Value Gain/(Loss) Hangover Joe's Holding Corporation 868,463 99,750 0.0002 - (99,750 ) Silver Verde May Mining Co., Inc. 246,294 46,488 0.2250 $ 55,416 8,928 WestMountain Gold, Inc. 918,000 918 0.3500 $ 321,300 320,382 Totals 2,032,757 $ 147,156 $ 376,716 $ 229,560 As of December 31, 2014 Accumulated Share Market/Cost Unrealized Company Name Shares Cost Price Value Gain/(Loss) Omni Bio Pharmaceutical, Inc. 1,707,107 $ 193,635 $ 0.3695 $ 630,776 $ 437,141 Hangover Joe's Holding Corporation 868,463 99,750 0.0028 2,432 (97,318 ) Silver Verde May Mining Co., Inc 246,294 46,488 0.2100 51,722 5,234 WestMountain Gold, Inc. 918,000 918 0.3500 321,300 320,382 Totals 3,739,864 $ 340,791 $ 1,006,230 $ 665,439 During the three months ended March 31, 2015, the Company's investment in Omni Bio Pharmaceutical, Inc. was determined to have an other than temporary decline in value. The investment was fully impaired resulting in a loss on impairment of available for sale marketable securities of $193,634. Investments in Nonmarketable Securities During December 2012, NexCore Healthcare Capital Corp. entered into a restructuring whereby the Company received a stock dividend consisting of 1,645,000 Class B Units of NexCore Real Estate, LLC. NexCore Real Estate is a private company with no market for its stock. The stock dividend received in NexCore Real Estate was recorded at its cost basis which was $0. The investment in NexCore Healthcare is deemed to be nonmarketable because there is no active market for its stock. The investment in NexCore Healthcare is recorded at its original cost basis of $1,645. During February 2012, the Company converted its $30,000 convertible note receivable into 200,000 common shares of SKRP 16, Inc. This investment is recorded at our cost of $30,000. SKRP is in the process of obtaining their ticker symbol. As no market exists for the shares, this investment is deemed an investment in nonmarketable securities and is accounted for under the cost method. The Company's investments in nonmarketable securities accounted for under the cost method as of March 31, 2015 and December 31, 2014 are summarized below. March 31, 2015 December 31, 2014 Market/Cost Market/Cost Company Name Shares Units Value Shares Units Value Nonmarketable Securities: SKRP 16, Inc. 200,000 - $ 30,000 200,000 - $ 30,000 Nexcore Real Estate LLC (Class B Units) - 1,645,000 - 1,645,000 - Nexcore Healthcare Capital Corp 1,645,000 - 1,645 1,645,000 - 1,645 WestMountain Distressed Debt, Inc. 80,000 - - 80,000 - - Totals Shares or Units 1,925,000 1,645,000 $ 31,645 1,925,000 1,645,000 $ 31,645 In 2008 the Company invested $50,000 for 175,000,000 shares of common stock in Marine Exploration, which represented 39% of the outstanding common stock of Marine Exploration. The Company recorded this long-term investment using the equity method of accounting for investments. Any net income or net loss must be recorded against the Company's investment, not to exceed the original investment of $50,000. Marine Exploration incurred significant losses during 2008, and the investment was reduced to zero. On August 24, 2010, Marine Exploration authorized a reverse split of 1 new share for 500 old shares of their common stock. As of this date, the Company has less than 1% ownership in Marine Exploration.

Stockholders Equity

Stockholders Equity	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders Equity	(3) Stockholders Equity Common Stock There were 9,517,402 shares of common stock outstanding as of March 31, 2015 and December 31, 2014. No common shares were issued or cancelled during the three months ended March 31, 2015. Stock options On August 15, 2012, the Company approved the employee compensation plan and granted a total of 200,000 common stock options, to our employees. As stated in the compensation plan, these options have a four year term. Fifty percent of the options became vested and exercisable immediately, 25% on the first anniversary date of August 15, 2012, and 25% on the second anniversary date of August 15, 2013. The options have an exercise price of $0.27 per share, which was the fair value of the stock on the day of the grant. The fair value of the options was determined to be $41,038 using the Black Scholes option pricing model. The significant assumptions in the model included a risk free rate of 0.99%, a volatility input of 99.96% and using the simplified method, the expected term used in the calculation is 2.375 years. As of March 31, 2015, the full fair value of $41,038 has been expensed. The following table presents the activity for common stock options during the three months ended March 31, 2015: Weighted Average Options Exercise Price Outstanding - December 31, 2014 200,000 $ 0.27 Granted - - Forfeited/canceled - - Exercised - - Outstanding - March 31, 2015 200,000 $ 0.27 The weighted average remaining life of these 200,000 options as of March 31, 2015 and December 31, 2014 was 0.4 and 0.6 years respectively. The following table presents the composition of options outstanding and exercisable as of March 31, 2015 and December 31, 2014. The exercisable options have an intrinsic value of $54,000 and $56,000 as of March 31, 2015 and December 31, 2014. As of March 31, 2015: Options Outstanding Options Exercisable Range of Exercise Prices Number Life Number Price 0.27 200,000 0.4 200,000 0.27 As of December 31, 2014: Options Outstanding Options Exercisable Range of Exercise Prices Number Life Number Price 0.27 200,000 0.6 200,000 0.27

Related Parties

Related Parties	6 Months Ended
	Jun. 30, 2015
Related Party Transactions [Abstract]
Related Parties	(4) Related Parties Bohemian Companies, LLC and BOCO Investments, LLC are two companies under common control. Mr. Klemsz, our CEO, has been the Chief Investment Officer of BOCO Investments, LLC since March 2007. Since there is common control between the two companies and a relationship with our Company President, we are considering all transactions with Bohemian Companies, LLC and BOCO Investments, LLC, related party transactions. On January 1, 2008, we entered into a Service Agreement with Bohemian Companies, LLC to provide us with certain defined services. These services include financial, bookkeeping, accounting, legal and tax matters, as well as cash management, custody of assets, preparation of financial documents, including tax returns and checks, and coordination of professional service providers as may be necessary to carry out the matters covered by the Service Agreement. We compensated Bohemian Companies, LLC by reimbursing this entity for the allocable portion of the direct and indirect costs of each employee of Bohemian Companies, LLC that performs services on our behalf. We received invoices monthly from Bohemian Companies, LLC. This Service Agreement was terminated by mutual agreement of the parties on March 31, 2014. Total expenses incurred with Bohemian Companies were $3,000 for the three months ending March 31, 2014 and 2013. As of March 31, 2014 the Company had no balance due to Bohemian Companies, LLC. For the three months ended March 31, 2014 and 2013, the Company recorded management fee revenues of $-0- and $18,678, respectively, for asset management services performed on behalf of WestMountain Prime, LLC, a related party. The Company and WestMountain Prime, LLC are under common principal ownership. The asset management services contract between WestMountain Prime, LLC and the Company was terminated as of September 30, 2013. Historically, the Company earned management fees based on the size of the funds managed, and incentive income based on the performance of the funds. With the termination of the asset management services contract between the Company and WestMountain Prime, LLC, the Company no longer provides asset management services to any clients. Further, the Company has elected not to seek any new asset management services clients in the future but to concentrate solely on providing fee-based consulting services for marketing and media clients. For the three months ended March 31, 2014 and 2013, the Company recorded aggregate advisory/consulting revenue of $50,600 and $60,750, respectively. Of the $50,600 recorded in 2014, $38,000 is related party revenue for services performed on behalf of Nexcore Group LP and Bohemian Asset Management, Inc. The Company, Nexcore and Bohemian are under common principal ownership. Of the $60,750 recorded in 2013, $30,750 is related party revenue for services performed on behalf of Nexcore Group LP and WestMountain Gold Inc. The Company, Nexcore and WestMountain Gold, Inc. are under common principal ownership. On October 10, 2013, the Company signed a Marketing/Media Consulting Agreement that was effective October 1, 2013 with Bohemian Asset Management, Inc., a related party due to common ownership. This agreement has an original expiration date of December 31, 2014. We will be paid $20,000 per quarter for general marketing and consulting services, due and payable in advance on the first of each quarter. As of March 31, 2014 and December 31, 2013, the Company had $16,450 and $394,800, respectively, of accounts receivable from related parties. The amount due in 2013 represents distribution income due from Nexcore Real Estate LLC. The receivable was collected in January 2014. On September 29, 2010 CapTerra Financial Group, Inc. merged with Nexcore Group LP (“Nexcore”). The Company provided advisory services related to the transaction and for those services received 1,645,000 warrants. In December 2010, these warrants were exercised for common stock of Nexcore Group LP. As of March 31, 2014 and December 31, 2013, no active market existed for these securities and so the Company kept the value of this investment on the books at the aggregate exercise price of $1,645. The equity securities are restrictive securities. On January 25, 2013, Nexcore Real Estate, LLC declared $0.01 per share cash dividend payable on February 18, 2013 to holders of NexCore common stock of record on February 4, 2013. As of that date, the Company owned 1,645,000 shares of common stock. In the first quarter 2013, we received a cash dividend of $16,450 that was recorded as dividend on nonmarketable securities. On January 3, 2014, NexCore Healthcare Capital Corp. declared a $0.10 per share cash dividend to holders of NexCore common stock of record on January 16, 2014. As of that date, the Company owned 1,645,000 shares of common stock and received a cash dividend of $164,500. As of March 31, 2014 and December 31, 2013, the following investments in marketable and nonmarketable securities were held in related parties due to common principal ownership. March 31, 2014 December 31, 2013 Market/Cost Market/Cost Company Name Shares Units Value Shares Units Value Marketable Securities: Hangover Joe's Holding Corporation (formerly Accredited Members Holding Corporation) 928,463 - $ 26,276 928,463 - $ 16,061 WestMountain Gold, Inc. (formerly WestMountain Index Advisor, Inc.) 918,000 - 780,300 866,000 - 640,840 Total Shares or Units 1,846,463 - $ 806,576 1,794,463 - $ 656,901 Nonmarketable Securities: Nexcore Real Estate LLC (Class B Units) - 1,645,000 $ - - 1,645,000 $ - Nexcore Healthcare Capital Corp 1,645,000 - 1,645 1,645,000 - 1,645 Totals Shares or Units 1,645,000 1,645,000 $ 1,645 1,725,000 1,645,000 $ 1,645

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2015
Subsequent Events [Abstract]
Subsequent Events	(5) Subsequent Events On October 17, 2014, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $25,000. Repayment of the loan was due on or before April 16, 2015. On April 18, 2015 we carried over the principal and total interest due to a new note. The new principal amount is $27,256. The new note carries an interest rate of 18% per annum until paid in full. Repayment of the loan is due on or before October 18, 2015. On May 4, 2015, we entered into a Promissory Note Agreement with WestMountain Distressed Debt, Inc., a related party, in the amount of $10,000. The note bears an interest rate of 18% per annum until paid in full. Repayment of the loan is due on or before November 4, 2015. On May 7, 2015 Omni Bio Pharmaceutical filed a Form 8K. This company has been unsuccessful in its fundraising and partnering/licensing efforts and does not anticipate being able to raise sufficient capital to continue operations. Consequently, the Board of Directors of Omni Bio approved an orderly wind down, including negotiations with its senior secured creditor, Bohemian Investments, LLC. As a result of this other than temporary loss in value, the Company's investment in this Company was fully impaired during the three months ended March 31, 2015 resulting in a loss of $193,634.

Nature of Organization and Su11

Nature of Organization and Summary of Significant Accounting Policies (Policy)	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Organization and Basis of Presentation	Nature of Organization and Basis of Presentation WestMountain Company, formerly known as WestMountain Asset Management, Inc. , ("we"," our" or the "Company"), was incorporated in the state of Colorado on October 18, 2007 and on this date approved its business plan and commenced operations. The consolidated financial statements include the financial information of WestMountain Company and its wholly owned subsidiaries, WestMountain Business Consulting, Inc., WestMountain Allocation Analytics, Inc. and WestMountain Valuation Services Inc. All significant intercompany accounts and transactions have been eliminated.
Unaudited Financial Information	Unaudited Financial Information The accompanying financial information as of March 31, 2015 and for the three months ended March 31, 2015 and 2014 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company's financial position at March 31, 2015 and its operating results for the three months ended March 31, 2015 and 2014 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company's annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") for the year ended December 31, 2014. The results of operations for the three months ended March 31, 2015 is not necessarily an indication of operating results to be expected for the year.
Commitments and Contingencies	Commitments and Contingencies Based on currently available information, the Company believes that it is remote that future costs related to known contingent liability exposures will exceed current accruals by an amount that would have a material adverse impact on our financial statements. As the Company learns new facts concerning contingencies, the Company reassesses its position both with respect to accrued liabilities and other potential exposures. In the case of all known contingencies, the Company accrues a liability when the loss is probable and the amount is reasonably estimable. The Company does not reduce these liabilities for potential insurance or third-party recoveries.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Available-for-sale securities are accounted for on a specific identification basis. As of March 31, 2015 and December 31, 2014 respectively, we held available-for-sale marketable securities with an aggregate fair value of $376,716 and $1,006,230 respectively. As of March 31, 2015, all of our available-for-sale securities were invested in publically traded equity holdings. Available-for-sale securities were classified as current based on the percentage of the equity controlled by the Company as well as our intended use of the assets. The Company recognized unrealized losses, net of tax, in accumulated other comprehensive (loss) income for the three months ended March 31, 2015 and 2014 in the amounts of ($274,362) and $3,321, respectively.

Nature of Organization and Su12

Nature of Organization and Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis	The Company's assets measured at fair value on a recurring basis subject to the disclosure requirements of ASC 820 at March 31, 2015 and December 31, 2014, were as follows: Assets and Liabilities Measured at Fair Value on a Recurring Basis as of March 31, 2015 Quoted Prices in Significant Active Markets for Other Significant Identical Assets and Observable Unobservable Balance as of Liabilities Inputs Inputs March 31, Description (Level 1) (Level 2) (Level 3) 2015 Assets: Available-for-sale marketable securities $376,716 $ - $ - $376,716 Assets and Liabilities Measured at Fair Value on a Recurring Basis as of December 31, 2014 Quoted Prices in Significant Active Markets for Other Significant Identical Assets and Observable Unobservable Balance as of Liabilities Inputs Inputs December 31, Description (Level 1) (Level 2) (Level 3) 2014 Assets: Available-for-sale marketable securities $1,006,230 $ - $ - $1,006,230

Investments (Tables)

Investments (Tables)	6 Months Ended
	Jun. 30, 2015
Investments, Debt and Equity Securities [Abstract]
Schedule of Investments in Available for Sale Marketable Securities	The Company's investments in available for sale marketable securities as of March 31, 2015 and December 31, 2014 are summarized below. As of March 31, 2015 Accumulated Share Market/Cost Unrealized Company Name Shares Cost Price Value Gain/(Loss) Hangover Joe's Holding Corporation 868,463 99,750 0.0002 - (99,750 ) Silver Verde May Mining Co., Inc. 246,294 46,488 0.2250 $ 55,416 8,928 WestMountain Gold, Inc. 918,000 918 0.3500 $ 321,300 320,382 Totals 2,032,757 $ 147,156 $ 376,716 $ 229,560 As of December 31, 2014 Accumulated Share Market/Cost Unrealized Company Name Shares Cost Price Value Gain/(Loss) Omni Bio Pharmaceutical, Inc. 1,707,107 $ 193,635 $ 0.3695 $ 630,776 $ 437,141 Hangover Joe's Holding Corporation 868,463 99,750 0.0028 2,432 (97,318 ) Silver Verde May Mining Co., Inc 246,294 46,488 0.2100 51,722 5,234 WestMountain Gold, Inc. 918,000 918 0.3500 321,300 320,382 Totals 3,739,864 $ 340,791 $ 1,006,230 $ 665,439
Investments in Nonmarketable Securities	March 31, 2015 December 31, 2014 Market/Cost Market/Cost Company Name Shares Units Value Shares Units Value Nonmarketable Securities: SKRP 16, Inc. 200,000 $ - 200,000 $ - Nexcore Real Estate LLC (Class B Units) - 1,645,000 - 1,645,000 - Nexcore Healthcare Capital Corp 1,645,000 - 1,645 1,645,000 - 1,645 WestMountain Distressed Debt, Inc. 80,000 - - 80,000 - - Totals Shares or Units 1,925,000 1,645,000 $ 1,645 1,925,000 1,645,000 $ 1,645

Related Parties (Tables)

Related Parties (Tables)	6 Months Ended
	Jun. 30, 2015
Related Parties Tables
Securities held in related parties due to common principal ownership	March 31, 2014 December 31, 2013 Market/Cost Market/Cost Company Name Shares Units Value Shares Units Value Marketable Securities: Hangover Joe's Holding Corporation (formerly Accredited Members Holding Corporation) 928,463 - $ 26,276 928,463 - $ 16,061 WestMountain Gold, Inc. (formerly WestMountain Index Advisor, Inc.) 918,000 - 780,300 866,000 - 640,840 Total Shares or Units 1,846,463 - $ 806,576 1,794,463 - $ 656,901 Nonmarketable Securities: Nexcore Real Estate LLC (Class B Units) - 1,645,000 $ - - 1,645,000 $ - Nexcore Healthcare Capital Corp 1,645,000 - 1,645 1,645,000 - 1,645 Totals Shares or Units 1,645,000 1,645,000 $ 1,645 1,645,000 1,725,000 $ 1,645

Stockholders Equity (Tables)

Stockholders Equity (Tables)	6 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Schedule of Common Stock Option Activity	The following table presents the activity for common stock options during the three months ended March 31, 2015: Weighted Average Options Exercise Price Outstanding - December 31, 2014 200,000 $ 0.27 Granted - - Forfeited/canceled - - Exercised - - Outstanding - March 31, 2015 200,000 $ 0.27
Schedule of Options Outstanding and Exercisable, by Exercise Price Range	The following table presents the composition of options outstanding and exercisable as of March 31, 2015 and December 31, 2014. The exercisable options have an intrinsic value of $54,000 and $56,000 as of March 31, 2015 and December 31, 2014. As of March 31, 2015: Options Outstanding Options Exercisable Range of Exercise Prices Number Life Number Price 0.27 200,000 0.4 200,000 0.27 As of December 31, 2014: Options Outstanding Options Exercisable Range of Exercise Prices Number Life Number Price 0.27 200,000 0.6 200,000 0.27

Nature of Organization and Su16

Nature of Organization and Summary of Significant Accounting Policies (Fair Value of Financial Instruments) (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Mar. 31, 2015	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Aggregate fair value of available-for-sale securities			$ 376,716	$ 1,006,230
Unrealized loss on investments in marketable equity securities, net of tax	$ (274,362)	$ 3,321

Related Parties (Details)

Related Parties (Details) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014
Related Party Transaction [Line Items]
Advisory/consulting fees, related parties			$ 53,600	$ 38,000
Advisory/consulting revenue from all sources			50,600	$ 60,750
Accounts receivable, related parties	$ 18,000		$ 12,000		$ 41,125
Cash dividend per share			$ .10	$ 0.01
Dividend income on nonmarketable securities				$ 180,950
Bohemian Companies Limited Liability Company [Member]
Related Party Transaction [Line Items]
Amount of transaction	3,000	$ 3,000
Accrued liabilities, related parties	0	1,000
Nexcore [Member]
Related Party Transaction [Line Items]
Accounts receivable, related parties	$ 394,800
Shares	1,645,000
Dividend income on nonmarketable securities		$ 16,450

Related Parties (Schedule of Re

Related Parties (Schedule of Related Party Investments) (Details) (USD $) - USD ($)	Mar. 31, 2015	Dec. 31, 2014
Related Party Transaction [Line Items]
Cost	$ 147,156	$ 340,791
Omni Bio Pharmaceutical Inc [Member]
Related Party Transaction [Line Items]
Shares		1,707,107
Cost		$ 630,779
Hangover Joes Holding Corp [Member]
Related Party Transaction [Line Items]
Shares	868,463	868,463
Cost		$ 2,432
WestMountain Gold, Inc. (formerly WestMountain Index Advisor, Inc.)
Related Party Transaction [Line Items]
Shares	918,000	918,000
Cost	$ 321,300	$ 982,309
Marketable Totals [Member]
Related Party Transaction [Line Items]
Shares	1,786,463	1,725,000
Cost	$ 321,300	$ 1,645
Nexcore Real Estate LLC Class B Units [Member]
Related Party Transaction [Line Items]
Shares	1,645,000	1,645,000
Cost	$ 1,645
Nexcore Real Estate LLC [Member]
Related Party Transaction [Line Items]
Shares	1,645,000	1,645,000
Cost	$ 1,645	$ 1,645
WestMountain Distressed Debt [Member]
Related Party Transaction [Line Items]
Shares	80,000	80,000
Non Marketable Totals [Member]
Related Party Transaction [Line Items]
Shares	1,725,000	1,645,000
Cost	$ 1,645	$ 1,645

Stockholders Equity (Details)

Stockholders Equity (Details) - USD ($)	6 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Aug. 15, 2012
Stockholders' Equity Note [Abstract]
Outstanding shares	9,517,402	9,517,402
Shares authorized under stock option plan		200,000	200,000
Terms of options per compensation plan agreement (in years)	4 years
Percentage of options that vest and are exercisable immediately			50.00%
Percentage of options that vest on the first anniversary date of August 15, 2012			25.00%
Percentage of options that vest on the second anniversary date of August 15, 2013			25.00%
Exercise price		$ 0.27
Fair value	$ 41,038
Risk free interest rate	99.00%
Volatility rate	99.00%
Expected life in years	2 years 1 month 6 days
Share-based compensation expense recognized during the period	$ 41,038

Stockholders Equity (Stock Opti

Stockholders Equity (Stock Option Activity) (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Stock option activity
Outstanding, beginning	200,000	200,000
Outstanding, ending		200,000
Weighted average exercise price, beginning	$ 0.27
Weighted average exercise price, ending		$ 0.27
Weighted average remaining life	4 months 2 days	6 months 1 day

Stockholders Equity (Exercisabl

Stockholders Equity (Exercisable and Outstanding Options by Exercise Price Range) (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2014	Mar. 31, 2015
Options by exercise price range
Options exercisable, intrinsic value		$ 56,000	$ 54,000
Minimum exercise price	$ 0.27	$ 0.27
Options outstanding		200,000	200,000
Options exercisable outstanding		200,000	200,000
Weighted average remaining life	4 months 2 days	6 months 1 day

Investments (Available for Sale

Investments (Available for Sale Marketable Securities) (Details) - USD ($)	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Shares		2,032,757	3,739,864
Cost		$ 147,156	$ 340,791
Market/Cost Value	$ 138,549	376,716	1,006,230
Accumulated Unrealized Gain/Loss		$ 229,560	$ 665,439
Omni Bio Pharmaceutical, Inc. [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares			1,707,107
Cost			$ 193,635
Share Price			$ 0.3695
Market/Cost Value			$ 630,776
Accumulated Unrealized Gain/Loss			$ 437,141
Hangover Joe's Holding Corporation [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares		868,463	868,463
Cost		$ 99,750	$ 99,750
Share Price		$ 0.0002	$ 0.0028
Market/Cost Value		$ 26,276	$ 2,432
Accumulated Unrealized Gain/Loss		$ (99,750)	$ (97,318)
Silver Verde May Mining Co., Inc [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares		246,294	246,294
Cost		$ 46,488	$ 46,488
Share Price		$ 0.2250	$ 0.2100
Market/Cost Value		$ 55,416	$ 51,722
Accumulated Unrealized Gain/Loss		$ 8,928	$ 5,234
WestMountain Gold, Inc. (formerly WestMountain Index Advisor, Inc.) [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares		918,000	918,000
Cost		$ 918	$ 918
Share Price		$ 0.3500	$ 0.3500
Market/Cost Value		$ 321,300	$ 321,300
Accumulated Unrealized Gain/Loss		$ 320,382	$ 320,382

Investments (Cost Method Nonmar

Investments (Cost Method Nonmarketable Investments) (Details) - USD ($)	Mar. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Shares/Units	3,570,000	3,570,000
Cost	$ 31,645	$ 31,645
SKRP 16 Inc [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares/Units	200,000	200,000
Cost	$ 30,000	$ 30,000
Nexcore Real Estate LLC [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares/Units	1,645,000	1,645,000
Cost
Nexcore Healthcare Capital [Member]
Schedule of Available-for-sale Securities [Line Items]
Shares/Units	1,645,000	1,645,000
Cost	$ 1,645	$ 1,645

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2015	Mar. 31, 2015
Subsequent Events [Abstract]
Promissory note agreement with related party		$ 25,000
New principal on promissory note that was carried over		27,256
Interest rate per annum	18.00%
Promissoy note		$ 10,000
Loss on investment	$ 193,634